Nervous Disorder TRIZ Cases

Targeting calcium permeable AMPA receptors lacking GluA2 prevents long-term cognitive deficits caused by early-life seizures.

ARBs protect the blood-brain barrier, preventing irreversible epileptogenesis while avoiding high drug development costs.

Tricyclic derivatives achieve low nM inhibition in the brain while avoiding systemic toxicity associated with peripheral kinase agents.

Modified glucagon analogs balance GIP potency and GLP-1 selectivity to treat diabetes.

Small molecule eIF2B activators modulate protein activity to treat neurodegenerative and metabolic disorders.

A C9orf72 immunogen induces high antibody titers to clear toxic dipeptide-repeat proteins.

Carrier proteins enable fusion molecules to cross the blood-brain barrier, delivering enzymes to treat central nervous system diseases.

High oleic acid sunflower oil and bile salts improve cannabidiol absorption while maintaining liver enzyme stability.

Selective neurotoxin dosing across specific muscle groups minimizes immune reactions and ptosis while maintaining migraine prevention efficacy.

A Varicella zoster virus glycoprotein E fused to an immunoglobulin Fc region creates a potent immunogen.

Masked antibodies use cleavable linkers to prevent premature target engagement, resolving systemic toxicity trade-offs.

Eicosapentaenoic acid compositions lower high-sensitivity C-reactive protein levels to treat cardiovascular disease.

TRIM proteins and STUbLs degrade misfolded nuclear proteins, reducing aggregates that cause neurodegenerative disorders.

Effervescent fentanyl tablets reduce required dose by forty-five percent while maintaining reliable pain relief and minimizing respiratory depression risks.

Antibodies recognize hyperphosphorylated Tau conformers to reduce aggregation while maintaining specificity against normal protein pathways.

Combines NMDA antagonist, CYP2D6 inhibitor, and opioid agonist to treat restless leg syndrome while reducing side effects from high opioid doses.

Magnesium N-acetyl-taurinate resolves the trade-off between efficacy and side effects in premenstrual syndrome treatment.

Specific ratio of lemon balm, linden, chamomile, and magnesium masks bitter taste while maintaining sedative effects for children.

Deglycosylated LRG1 binds LPHN2 to resolve weak ENG affinity, enabling TGF-beta-independent angiogenesis.

Distinct pyridine nitrogen oxide crystal forms block NaV1.8 channels to treat neuropathic pain with reduced side effects.

Multi-step extraction of Vicia faba beans removes antinutritional factors to isolate Sample A-1, which protects mice from strychnine-induced convulsions.

Combination therapy activates distinct biological pathways to prevent cell damage cascades, reducing side effects while improving therapeutic effectiveness.

Mavoglurant reduces opioid consumption by blocking mGluR5 receptors, lowering overdose risk while maintaining pain relief.

A mixture extract of goji berries, mulberries, and jujubes enhances immune response through synergistic cytokine expression.

Affinity maturation achieves 10 pM binding to IL-1R1, resolving short half-life and low potency trade-offs in existing treatments.

Optimized administration rate and concentration prevent cell clumping at the injection site while enhancing therapeutic efficacy.

Viscosity-adjusting agents enable high drug loading in spherical granules while reducing moisture absorption.

A replication competent retroviral vector system stably expresses gag, pol, and env genes to produce viral particles with prolonged infectivity.

Combining erlotinib and isoniazid modulates EGFR and Nrf2 pathways in glioma treatment.

Engineered antibodies bind tau protein to inhibit aggregation and induce phagocytosis, reducing neuronal damage from neurodegenerative diseases.

An anti-c-Met antibody agonist activates the receptor to promote wound healing and reduce kidney damage.

Replacing murine constant regions with human sequences reduces antigenicity while maintaining therapeutic effectiveness against B cell malignancies.

Sol-gel derived titania reservoirs maintain constant brain tissue drug concentrations over years using zero-order kinetics.

A pulsatile caffeine formulation uses pH-sensitive polymers to control release timing.

VHH antibodies with isoelectric points above 8.5 bypass receptor saturation limits to deliver therapeutic compounds across the blood-brain barrier.

Conjugating 40 kDa branched PEG to truncated IL-11 extends serum half-life while reducing plasma expansion.

A synthetic Ala673Val peptide inhibits beta-amyloid aggregation to support diagnostic screening.

Deoxyribonucleosides bypass defective metabolic pathways to hyperstimulate POLG and restore mtDNA levels in replication machinery defects.

Merges agomelatine with lithium, carbamazepine, or valproate to treat mood disorders while reducing side effects.

Adding ondansetron to acetylcholine esterase inhibitor therapy eliminates dose-limiting nausea and vomiting, allowing fourfold dose increases.

Formula I compounds target Nav1.7, Nav1.3, and Nav1.9 subtypes to reduce CNS and cardiovascular side effects.

Pyridazine derivatives inhibit p38α MAPK to suppress pro-inflammatory cytokines, arresting Alzheimer's disease progression.

A compressed tablet uses a blend of direct compressible and non-direct compressible erythritol particles to enhance salivation and mouthfeel.

Ghrelin administration reduces oxidative stress and inflammation, preventing long-term damage from mild brain injury.

Nonracemic amisulpride compositions adjust R to S enantiomer ratios to minimize dopamine D2 side effects while enhancing antidepressant efficacy.

Truncated erythropoietin variants eliminate hematopoietic side effects while maintaining neuroprotection.

Small molecules induce conformational changes in spliceosomes, addressing alternative splicing patterns.

CYP46A1 inhibitors target cholesterol 24-hydroxylase to treat neurodegenerative diseases lacking effective modulation of NMDA receptor activity.

Modifying SERPIN peptide sequences improves stability and LRP1 affinity for treating inflammatory conditions.